A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU [carmustine] Versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma.
Phase of Trial: Phase III
Latest Information Update: 29 Oct 2015
At a glance
- Drugs Benzylguanine (Primary) ; Carmustine
- Indications Glioblastoma
- Focus Therapeutic Use
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 13 Jan 2012 Planned end date 1 Jan 2012 added as reported by ClinicalTrials.gov.